[Myocardial bridge: description, significance, treatment]

C Bourmayan1, M Desnos, C Guérot

  • 1Service de cardiologie I, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75908 Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|August 10, 2001
PubMed

Insights

Myocardial bridges, an anomalous coronary artery path, can cause serious heart issues like ischemia and sudden death. Angioplasty and stenting offer effective treatment for symptomatic cases resistant to medication.

Area of Science:

  • Cardiology
  • Vascular Anatomy
  • Clinical Medicine

Context:

  • Myocardial bridges are congenital anomalies where a segment of a coronary artery runs through the heart muscle.
  • The clinical significance of myocardial bridges ranges from asymptomatic to severe ischemic events.
  • Historically, management has been conservative, with surgical intervention reserved for refractory cases.

Purpose:

  • To review the current understanding of myocardial bridges and their clinical implications.
  • To discuss the diagnostic signs and symptoms associated with symptomatic myocardial bridges.
  • To evaluate the evolving treatment strategies for myocardial bridges, including medical, surgical, and interventional approaches.

Summary:

  • Myocardial bridges represent an abnormal course of coronary arteries, potentially leading to myocardial ischemia, infarction, or sudden death.
  • Symptomatic myocardial bridges manifest with electrocardiographic, scintigraphic, or metabolic evidence of ischemia.
  • While medical management is common, angioplasty and stenting have emerged as effective alternatives for patients unresponsive to conservative therapy.

Impact:

  • This review highlights the potential severity of myocardial bridges, emphasizing the need for accurate diagnosis and timely intervention.
  • It underscores the growing role of percutaneous coronary interventions like angioplasty and stenting in managing complex myocardial bridge cases.
  • The findings provide valuable insights for clinicians managing patients with coronary artery anomalies and ischemic heart disease.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...